Direct molecular testing for isoniazid and rifampicin resistance from respiratory specimens of patients with tuberculosisCarolin Kreiter, Torsten Bauer, Anna Streubel et al.|Unknown|2013Cited by 0
Prognostic value of ERCC1 expression in advanced non-small cell lung cancer (NSCLC)Jens Kollmeier, Torsten Bauer, Torsten Blum et al.|European Respiratory Journal|2012Cited by 0
KRAS mutations in non-small cell lung cancer (NSCLC) – Experiences by routine molecular testing in a German lung cancer centreChristian Boch, Torsten Bauer, Torsten Blum et al.|European Respiratory Journal|2011Cited by 0
Molekularbiologische Resistenzprüfung gegenüber Isoniazid und Rifampicin aus Direktmaterial von TuberkulosepatientenCarolin Kreiter, T Mairinger, Holger Rüssmann et al.|Pneumologie|2013Cited by 0